NIH HIV TWIN GENE THERAPY STUDY APPROVED BY RAC; TOTAL OF FIVE PROTOCOLS RECEIVE OKAY FROM RAC, INCLUDING FIRST FOR CHRONIC GRANULOMATOUS DISEASE
Executive Summary
A Phase I/II protocol to evaluate the safety and efficacy of infusing genetically-engineered T-cells from HIV-negative twins to their HIV-positive twins received approval without modifications from the National Institutes of Health Recombinant DNA Advisory Committee March 6.